Proteonomix is a biotechnology company engaged in developing therapeutics based upon the use of human cells and their derivatives.
Proteonomix further intends to use THOR BioPharma to serve as the platform for technology for its Pharmaceutical business.
Intially, THOR BioPharma will focus on licensing and developing therapeutic agents for critically ill patients.